Sudeep Pharma’s Rs 895-crore IPO has seen strong early interest, already oversubscribed on Day 1 with robust demand from retail and NII investors. A rising grey-market premium hints at positive listing expectations. Backed by strong financial growth, advanced manufacturing capabilities, and favourable sector tailwinds, the issue appeals to long-term investors.Read More
India’s Q2 earnings have strengthened market sentiment, but Marcellus Investment Managers’ Rakshit Ranjan says the next market rally will be selective, not broad-based. Autos, discretionary consumption, and healthcare look attractive, while cyclicals, banks and real estate face valuation risks. With GST cuts and a possible US–India trade deal, investors must focus on sector-specific opportunities.Read More
Indian government bonds are set for a quiet start on Monday. The Indian rupee’s new record low is a major concern. Investors are watching the currency’s movement closely. Upcoming economic data will also be a key focus. The Reserve Bank of India’s actions on liquidity and bond yields are under scrutiny.Read More
HG Infra shares: The company, in joint venture with Kalpataru Projects, has become the L-1 bidder for a ₹1,415 crore Maharashtra Metro Rail project. HG Infra will execute 40% of the work, while Kalpataru will handle the remaining 60%.Read More
TCS shares may be in focus after the company reported an adverse US appellate court ruling in a trade secrets case filed by CSC, now part of DXC. The court upheld $194 million in damages but vacated an injunction, allowing TCS to continue operations. The company is reviewing the verdict, exploring legal options and will make accounting provisions as required.Read More
Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.
